Product How it works Pricing Blog FAQ About Contact

Pfizer dividend per share

Pfizer declared $1.72 per share for the fiscal year ended 31 December 2025, +1.8% on the year before ($1.69). Below are 10 fiscal years of dividends declared per share, each with the annual report (10-K) it was filed in. Over the series the dividend rose in 9 years and was cut in 0.

Pfizer (PFE): dividends declared per share, as filed with the SEC
Fiscal year ended Dividend per share Change Filed in
31 December 2025 $1.72 +1.8% 10-K filed 26 February 2026 ↗
31 December 2024 $1.69 +2.4% 10-K filed 26 February 2026 ↗
31 December 2023 $1.65 +2.5% 10-K filed 27 February 2025 ↗
31 December 2022 $1.61 +2.5% 10-K filed 22 February 2024 ↗
31 December 2021 $1.57 +2.6% 10-K filed 23 February 2023 ↗
31 December 2020 $1.53 +4.8% 10-K filed 24 February 2022 ↗
31 December 2019 $1.46 +5.8% 10-K filed 25 February 2021 ↗
31 December 2018 $1.38 +6.2% 10-K filed 27 February 2020 ↗
31 December 2017 $1.30 +6.6% 10-K filed 28 February 2019 ↗
31 December 2016 $1.22 — 10-K filed 28 February 2019 ↗

What this figure is, exactly

It is dividends declared per share: what the board declared for the fiscal year, as Pfizer itself tags it in the XBRL data filed with each annual report. Declared and paid can differ in a given year when a quarterly dividend declared in December is paid in January: the declared figure counts it in the year of the declaration. The company also tagged cash dividends paid per share from fiscal 2010 to 2017; this page uses the series the company currently reports, and does not mix the two.

Each fiscal year is named by the date it ended, because Pfizer's fiscal year coincides with the calendar year. For each year the figure comes from the 10-K for that year itself, the report that was audited for it; later 10-Ks repeat it as a comparative, and that repetition is used only to detect stock splits. Where a later 10-K tags a year differently without a split, the row says so.

No restatement at a whole-number ratio appears in the series, so no stock split affects these figures.

Where each figure comes from

From the CommonStockDividendsPerShareDeclared concept in the XBRL financial data Pfizer files with the U.S. Securities and Exchange Commission alongside its Form 10-K (SEC registrant CIK 78003). The "Filed in" column opens the filing index of that 10-K at sec.gov, where the full report and its XBRL instance are public. The data was read from the SEC on 15 October 2026.

What feeds every figure on Celsmar: data sources; figures that were published wrong and fixed: corrections register.

Frequently asked questions

How much does Pfizer pay in dividends per share?
Pfizer declared $1.72 per share for the fiscal year ended 31 December 2025, as reported in its annual report filed with the SEC on 26 February 2026. The figure is the company's own XBRL tag for dividends declared per share; it is not an estimate.
Is this the dividend I will receive?
No. This is the dividends declared per share for a whole fiscal year, as the company reports it in its 10-K. What you receive depends on the shares you hold on each record date and on the quarterly payments the board declares after this report. For the next payment date, the source is the company's own dividend announcement, not its annual report.
Does this cover the calendar year?
Yes: Pfizer's fiscal year ends on 31 December, so each row covers a calendar year. The figure in a 10-K is always for the company's fiscal year, which is why each row names the exact date it ended.
Where does each figure come from and can I check it?
From the XBRL data the company files with the SEC alongside its 10-K, under the concept CommonStockDividendsPerShareDeclared. Each row links the filing index of that 10-K at sec.gov, where the full report and its XBRL instance are public. For each fiscal year the figure is the one in the 10-K for that year itself; later filings are used only to detect stock splits, and if one tags the year differently the row says so.

Information compiled from public regulatory filings, for informational purposes. It is not financial advice nor a recommendation to buy or sell. A dividend declared in a past fiscal year does not predict future ones.